FERMT2 and breast carcinoma: Based on these evidences, we boldly speculate that in breast cancer, Kindlin-2 might activate molecular signaling pathways, such as integrin signaling and/or TGFβ signaling, to induce collagen expression, re-arrangement and changes in fiber shape, and ultimately affect breast nodule elasticity.